SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Sirna Therapeutics Inc
An SI Board Since December 1996
Posts SubjectMarks Bans Symbol
562 31 0 RNAI
Emcee:  advinfo Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
487BERLIN, Germany, May 14, 2002 (PRIMEZONE) -- atugen AG today announced a three ynigel bates-5/14/2002
486Ribozyme Pharmaceuticals, Inc. Reports First Quarter Financial Results; CompanSemiBull-5/7/2002
485ON24: Bumps in the road for Angiozyme and Heptazyme development biz.yahoo.comSemiBull-5/1/2002
484Competitive Technologies Licensee Provides Update on Clinical Trials RZYM ReporSemiBull-5/1/2002
483<i>Any thoughts on the clinical results announcement??</i> Good queSemiBull-4/30/2002
482Any thoughts on the clinical results announcement?? Thanks in advance. Should Thomas-4/30/2002
481Ribozyme Pharmaceuticals, Inc. Reports Fourth Quarter And Year End Financial ResSemiBull-3/24/2002
480Ribozyme Pharmaceuticals and Fujirebio Announce Collaboration To Develop and Comnigel bates-3/4/2002
479atugen AG signs Technology Evaluation Agreement with Kinetek Pharmaceuticals Bnigel bates-2/20/2002
478Thanks, Nigel. Just what we needed-- another patent announcement. The descriptThomas-2/19/2002
477ANGIOZYME(R) Patent Issued to Ribozyme Pharmaceuticals, Inc. BOULDER, Colo., Fenigel bates-2/19/2002
476Semi, Chuckle. What else is there for them to say. Suppose they could announceThomas-2/19/2002
475<i>Seems too early for a clinical trial announcement, but any guesses as tSemiBull-2/18/2002
474Seems too early for a clinical trial announcement, but any guesses as to what RZThomas-2/18/2002
473Ribozyme Pharmaceuticals, Inc. Appoints Dr. Nassim Usman to Chief Scientific OffSemiBull-1/30/2002
472CNBC's Investor Program 'Squawk Box' Features Ribozyme PharmaceuticaSemiBull-1/24/2002
471atugen AG Signs Target Validation Agreement with UCSF Berlin, Germany, 23 Janunigel bates-1/23/2002
470php4.eventsdigital.comnigel bates-1/21/2002
469Thanks, Nigel. Do you have a link from the webcast? TIA. Cheers, ThomasThomas-1/20/2002
468Couple of interesting things from the H&Q presentation... They expect the nenigel bates-1/18/2002
467Paula, >>The NEOT financing also contained resets that encouraged shortintuck-1/14/2002
466The NEOT financing also contained resets that encouraged shorting of the stock aXenaLives-1/12/2002
465BERLIN, Germany, Jan. 8, 2002 (PRIMEZONE) -- atugen AG announced today that it hnigel bates-1/9/2002
464C do you like RZYM as an investment here considering all the risk but the potentbob zagorin-1/8/2002
463Liposomes (fat globules) could be design to prefer certain organs or tissues to Cacaito-1/7/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News